Clinical trial
Phase II Clinical Trial of Interleukin-2 in AD
NCT06096090
Study timeline
Study start (actual)2022-01-01Date precision: day
Registry last updated2024-05-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer Diseaseunresolved
Interventions
Interleukin-2DRUG
PlaceboDRUG
Sponsors & collaborators
The Methodist Hospital Research Institutelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06096090 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.